<DOC>
	<DOC>NCT00769496</DOC>
	<brief_summary>A long-term study of BAY77-1931 (lanthanum carbonate) for hyperphosphatemia in patients undergoing hemodialysis</brief_summary>
	<brief_title>BAY 77-1931 Long-term Extension From Phase II Study</brief_title>
	<detailed_description />
	<mesh_term>Hyperphosphatemia</mesh_term>
	<criteria>Undergoing hemodialysis 3 times per week for chronic renal failure for the previous 3 consecutive months at least Predialysis serum phosphate levels of 10.0mg/dL during the washout period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>